Please login to the form below

European biotech

This page shows the latest European biotech news and features for those working in and with pharma, biotech and healthcare.

Mega-mergers dominate as buoyant markets lift biopharma

The biotech has also managed to increase its share price since its launch, a feat not frequently achieved in the sector. ... a new surge in confidence in European biotech.

Latest news

Novartis and J&J back latest €400m Medicxi biopharma fund

stage European biotechs, which have tended not have access to as much financial support as their counterparts in the US. ... to Medicxi, with European companies growing in stature and offering improved returns on investment for backers.
Illumina sets up first ex-US accelerator site in Cambridge

Boost for UK's golden triangle biotech region. Illumina has set up its first hub for genomics start-up funding outside the US, and has chosen Cambridge in the UK for
Gilead strikes $5.1bn deal to bolster ties with Galapagos

to take its stake in the Belgian biotech to 22%, as well as $1.1bn in opt-in payments for two late-stage drug candidates. ... on R&D, said the biotech’s CEO Onno van de Stolpe in a Bloomberg interview.
BioNTech raises €290m for mRNA cancer vaccine platform

a European biotech company. ... BioNTech was the first biotech to bring an mRNA-based individualised cancer vaccine targeting neoantigens into clinical trials.
Citryll snares €15m backing for its autoimmune disease NETs

New approach to tackling diseases such as lupus, RA. Dutch biotech Citryll has raised 15m ($17m) in first-round financing to help advance its new therapeutic approach to autoimmune diseases.

More from news
Approximately 21 fully matching, plus 34 partially matching documents found.

Latest Intelligence

Building European biotech firms to rival those of the US

Germany is European biotech’s sleeping giant. “Germany is Europe’s great untapped player in biotech,” said Richard. ... produced far fewer biotech companies than you would expect, it’s definitely the place to watch.”.
European biotech: a new generation of leaders emerges

biotechs’. The growing role of specialist venture capital. One of the key ingredients in these and other recent European biotech success stories is long-term backing from investors. ... European biotech is benefiting from this new support to translate
Building Europe’s next breakthrough biotechs

Cambridge's new Biomedical Campus is home to specialist NHS trusts, AstraZeneca's new HQ and biotech firms. ... How can the UK life science ecosystem produce even more biotech start-ups, and propel them to long-term success?
25 Women Leaders in UK Healthcare

It’s long been recognised that one of the biggest factors holding back UK and European biotech success has been a paucity of leaders, and that’s why efforts are being ... As well as overseeing the European communications group for Syneos Health, she
European venture funding for the life science sector

Capital markets infrastructure is a barrier. European biotech companies continue to find it hard to raise public money in Europe. ... Pockets of success on Euronext mask the fact that leading European venture groups primarily look to the Nasdaq, at least

More from intelligence
Approximately 2 fully matching, plus 7 partially matching documents found.

Latest appointments

Paris biocluster appoints Stéphane Roques as new chief

Former general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment
Apeiron bolsters management board

With more than 25 years’ experience in initial public offerings, mergers and acquisitions, as well as licensing and financial transactions in the chemical, biotech and pharma industries, Llewellyn-Davies most recently ... He said: “Apeiron is
Novimmune expands senior management team

He is currently a board member of German biotech Epiontis, and has previously served as chief financial officer of PregLem and chairman of Aimago. ... Prior to this, Dr Zimmerman was a European biotech analyst at UBS Investment Bank.
MRC Technology appoints director of technology transfer

Farquharson is additionally appointed to the EU Commission's Expert Group, advising on the European Biotech Directive's impact on patent law and R&D activities.
Creabilis names Catherine Moukheibir as chairman of the board

After an initial career in strategy consulting and investment banking, she held a number of senior management role at European biotech firms including CFO at Movetis, non-executive board member at

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Senior / Principal Medical Writer – Medical Education - UK &...: Excellent Salary and Benefits on offer

Account Director – Cheshire based Medical Communications Agency...: D.O.E

Scientific Director - Medical Education - Cheshire & London ...: Excellent Remuneration Package

Experienced / Senior Medical Writer - MedComms - Cardiff - Wales: Excellent Salary and Benefits on offer

Senior Medical Writer – Leading Medical Communications Agency – ...: Highly Competitive Remuneration Package

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Graduate / Entry Level Opportunities – Medical Communications – ...: Highly Competitive Remuneration Package

Account Executive: Salary TBC

Account Director, Medical Education: Salary TBC

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Senior Medical Writer: Salary TBC

Account Supervisor: Salary TBC

Scientific Director - Medical Communications Agency - New York: Excellent Remuneration Package

Associate Medical Writer / Entry Level Medical Writer - Medical ...: DOE

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Subscribe to our email news alerts

PMHub

Add my company

Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...